A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab

NCT05660122 · clinicaltrials.gov ↗

COMPLETED

Status

2852

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Fexuprazan Hydrochloride

Sponsor

Daewoong Pharmaceutical Co. LTD.